curasan Gains CE Mark for Spinevisc Hyaluronic Acid
curasan is launching Spinevisc® hyaluronic acid for the treatment of facet syndrome. Oct 01, 2019
Zimmer Biomet Recalls Certain Legacy Biomet Products
Zimmer Biomet voluntarily recalled various legacy Biomet products due to cleaning processes that could lead to elevated bacterial endotoxin and residual debris. Oct 01, 2019
Back 2 Basics Gains FDA Clearance for Carbon Interbody Cages
Back 2 Basics received FDAÂ 510(k) clearance to market eCarbon anterior cervical and posterior lumbar Interbody devices. Oct 01, 2019
Pixee Medical Gains Funding for Augmented Reality Tools
Pixee Medical closed a €2MM Series A funding to support global commercialization of augmented reality tools for surgical planning and navigation. Oct 01, 2019
Conformis and Stryker Enter Development, License and Distribution Agreement for PSI Knee Technology
Conformis and Stryker entered development, license and distribution agreements for patient specific instrument technology. Oct 01, 2019
Cellular Biomedicine’s ReJoin for Knee OA Accepted for Trial in China
Cellular Biomedicine's drug application for ReJoin® therapy for knee osteoarthritis was accepted for a Phase II clinical trial in China. Sep 30, 2019
Onkos Surgical Launches My3D Personalized Surgery Platform
Onkos Surgical launched the My3D Personalized Solutions platform, powered by 3D Systems' VSP® (Virtual Surgical Planning) Orthopaedics. Sep 27, 2019
DiscGenics IDCT Study Update
Preclinical study results demonstrated that intradiscal injection of Discogenic Cells, the active ingredient in DiscGenics' IDCT allogeneic cell therapy, may be a viable treatment for degenerative disc disease. Sep 27, 2019
DeGen Medical Gains New FDA Clearances
DeGen Medical received FDA clearance to market the F1 MPS Modular Pedicle Screw System for JOUST Minimally Invasive Surgery and the Cyclops Anterior Cervical Plate. Sep 27, 2019
Medical Device Industry Stakeholders Seek Permanent Repeal of Medical Device Tax
The Medical Device Manufacturers Association, the Advanced Medical Technology Association, the Medical Imaging & Technology Alliance and numerous industry stakeholders are asking the U.S. Congress to permanently repeal the 2.3% medical device excise tax. Sep 27, 2019
